RUNX2 and breast carcinoma: There is evidence that Runx2 can regulate the expression of genes and matrix metalloproteinases related to bone metastasis in breast cancer cells, promote breast cancer to degrade the cellular matrix, destroy the basement membrane and invade blood vessels or lymphatic vessels, and facilitate the colonization of tumor cells at distant metastatic sites [28, 29].